Research & Development

The following describes the research interests of a global organisation and includes information on products that are not yet licensed or available in the UK.

CSL Behring is a global specialty biopharmaceutical company which aims to identify, develop and commercialise important, new, biotherapeutic products that help to prevent or treat serious medical conditions. The company is committed to investing in its future product portfolio and capabilities in the areas of immunoglobulins, specialty products, haemophilia products and possible breakthrough medicines.

CSL Behring also has a strong commitment to funding research and development of protein-based medicines for unmet medical needs, which underpins its continued growth.

CSL Behring operates as one integrated global research and development organisation. We assemble co-ordinated global project teams, drawing together staff from different countries depending on their expertise. These teams rely on a project management framework that facilitates collaboration across national and cultural boundaries.

R&D Partnerships

To complement in-house expertise, we also draw on strategic partnerships with academic institutions and other organisations globally. These collaborative partnerships support a range of effective research programmes, including both basic and applied research in plasma derived and recombinant protein-based product development.